Rhenman & Partners Asset Management AB as of March 31, 2015
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 89 positions in its portfolio as reported in the March 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Select Sector Spdr Tr opt | 5.4 | $32M | 440k | 72.50 | |
| Alexion Pharmaceuticals | 3.4 | $20M | 115k | 173.30 | |
| Celgene Corporation | 2.9 | $17M | 151k | 115.28 | |
| Merck & Co (MRK) | 2.9 | $17M | 300k | 57.48 | |
| Biogen Idec (BIIB) | 2.9 | $17M | 41k | 422.24 | |
| Amgen (AMGN) | 2.7 | $16M | 99k | 159.85 | |
| Alkermes (ALKS) | 2.6 | $16M | 258k | 60.97 | |
| Gilead Sciences (GILD) | 2.6 | $16M | 159k | 98.13 | |
| UnitedHealth (UNH) | 2.6 | $15M | 130k | 118.29 | |
| CVS Caremark Corporation (CVS) | 2.5 | $15M | 145k | 103.21 | |
| Actavis | 2.3 | $14M | 45k | 297.62 | |
| Abbvie (ABBV) | 2.2 | $13M | 220k | 58.54 | |
| Cardinal Health (CAH) | 2.1 | $13M | 141k | 90.27 | |
| Esperion Therapeutics (ESPR) | 2.0 | $12M | 127k | 92.60 | |
| Rite Aid Corporation | 1.9 | $11M | 1.3M | 8.69 | |
| Incyte Corporation (INCY) | 1.9 | $11M | 120k | 91.66 | |
| Nektar Therapeutics | 1.9 | $11M | 997k | 11.00 | |
| Universal Health Services (UHS) | 1.7 | $10M | 87k | 117.71 | |
| Regeneron Pharmaceuticals (REGN) | 1.7 | $9.9M | 22k | 451.50 | |
| Jazz Pharmaceuticals (JAZZ) | 1.6 | $9.5M | 55k | 172.78 | |
| BioMarin Pharmaceutical (BMRN) | 1.6 | $9.3M | 75k | 124.63 | |
| Eli Lilly & Co. (LLY) | 1.6 | $9.4M | 129k | 72.65 | |
| Medivation | 1.5 | $8.9M | 69k | 129.07 | |
| Anthem | 1.5 | $8.8M | 57k | 154.40 | |
| McKesson Corporation (MCK) | 1.4 | $8.6M | 38k | 226.21 | |
| Bristol Myers Squibb (BMY) | 1.4 | $8.3M | 129k | 64.50 | |
| Valeant Pharmaceuticals Int | 1.2 | $7.1M | 36k | 198.61 | |
| Receptos | 1.2 | $7.2M | 44k | 164.90 | |
| Cyberonics | 1.2 | $7.0M | 108k | 64.92 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.1 | $6.8M | 58k | 117.97 | |
| BECTON DICKINSON & CO Com Stk | 1.1 | $6.7M | 47k | 143.59 | |
| Orexigen Therapeutics | 1.1 | $6.5M | 832k | 7.83 | |
| ISIS Pharmaceuticals | 1.1 | $6.5M | 102k | 63.67 | |
| Intercept Pharmaceuticals In | 1.1 | $6.5M | 23k | 282.00 | |
| Cempra | 1.1 | $6.4M | 185k | 34.31 | |
| Community Health Systems (CYH) | 1.0 | $6.2M | 118k | 52.28 | |
| ACADIA Pharmaceuticals (ACAD) | 0.9 | $5.6M | 171k | 32.59 | |
| Hca Holdings (HCA) | 0.9 | $5.6M | 74k | 75.23 | |
| Alnylam Pharmaceuticals (ALNY) | 0.9 | $5.5M | 53k | 104.42 | |
| Supernus Pharmaceuticals (SUPN) | 0.9 | $5.5M | 451k | 12.09 | |
| Medtronic | 0.9 | $5.4M | 69k | 77.99 | |
| Laboratory Corp. of America Holdings | 0.8 | $4.9M | 39k | 126.10 | |
| Cerner Corporation | 0.8 | $4.8M | 66k | 73.26 | |
| Revance Therapeutics | 0.8 | $4.9M | 236k | 20.73 | |
| Dex (DXCM) | 0.8 | $4.8M | 77k | 62.34 | |
| AmSurg | 0.8 | $4.7M | 76k | 61.53 | |
| Tetraphase Pharmaceuticals | 0.8 | $4.5M | 122k | 36.64 | |
| Aetna | 0.7 | $4.4M | 41k | 106.54 | |
| Intra Cellular Therapies (ITCI) | 0.7 | $4.4M | 183k | 23.88 | |
| AmerisourceBergen (COR) | 0.7 | $4.3M | 38k | 113.66 | |
| Clovis Oncology | 0.7 | $4.0M | 54k | 74.22 | |
| Abiomed | 0.7 | $3.9M | 55k | 71.58 | |
| Omnicare | 0.7 | $3.9M | 50k | 77.06 | |
| Keryx Biopharmaceuticals | 0.6 | $3.8M | 297k | 12.73 | |
| Thoratec Corporation | 0.6 | $3.6M | 87k | 41.89 | |
| Rigel Pharmaceuticals | 0.6 | $3.6M | 1.0M | 3.57 | |
| Centene Corporation (CNC) | 0.6 | $3.4M | 48k | 70.69 | |
| Hologic (HOLX) | 0.6 | $3.3M | 101k | 33.03 | |
| Celldex Therapeutics | 0.6 | $3.3M | 119k | 27.87 | |
| Endologix | 0.6 | $3.3M | 194k | 17.07 | |
| Perrigo Company (PRGO) | 0.6 | $3.3M | 20k | 165.55 | |
| Macrogenics (MGNX) | 0.6 | $3.3M | 106k | 31.37 | |
| St. Jude Medical | 0.5 | $3.2M | 49k | 65.41 | |
| Ariad Pharmaceuticals | 0.5 | $3.2M | 387k | 8.24 | |
| Teva Pharmaceutical Industries (TEVA) | 0.5 | $3.1M | 50k | 62.30 | |
| Anthera Pharmaceutcls | 0.5 | $3.1M | 701k | 4.47 | |
| Insulet Corporation (PODD) | 0.5 | $3.0M | 90k | 33.36 | |
| Ligand Pharmaceuticals In (LGND) | 0.5 | $3.0M | 39k | 77.10 | |
| Tesaro | 0.5 | $3.0M | 53k | 57.40 | |
| Stryker Corporation (SYK) | 0.5 | $3.0M | 32k | 92.25 | |
| Array BioPharma | 0.5 | $2.9M | 400k | 7.37 | |
| Cepheid | 0.5 | $3.0M | 52k | 56.90 | |
| Heartware Intl Inc note 3.500%12/1 | 0.5 | $2.9M | 33k | 87.76 | |
| Xencor (XNCR) | 0.5 | $2.9M | 190k | 15.32 | |
| Omnicell (OMCL) | 0.5 | $2.8M | 80k | 35.10 | |
| Achillion Pharmaceuticals | 0.5 | $2.8M | 280k | 9.86 | |
| Edwards Lifesciences (EW) | 0.5 | $2.7M | 19k | 142.47 | |
| Dynavax Technologies Corporation | 0.5 | $2.8M | 123k | 22.43 | |
| Tandem Diabetes Care | 0.4 | $2.6M | 209k | 12.62 | |
| Kite Pharma | 0.4 | $2.6M | 45k | 57.69 | |
| Endo International | 0.4 | $2.4M | 27k | 89.71 | |
| Celladon | 0.4 | $2.3M | 120k | 18.94 | |
| Myriad Genetics (MYGN) | 0.4 | $2.1M | 60k | 35.40 | |
| Avalanche Biotechnologies In | 0.3 | $1.7M | 43k | 40.51 | |
| Lexicon Pharmaceuticals | 0.2 | $1.5M | 1.6M | 0.94 | |
| Mirati Therapeutics | 0.2 | $1.3M | 45k | 29.32 | |
| Threshold Pharmaceuticals | 0.1 | $818k | 202k | 4.06 | |
| Bind Therapeutics | 0.1 | $733k | 134k | 5.49 | |
| Chimerix (CMRX) | 0.1 | $535k | 14k | 37.68 |
